India, Aug. 18 -- Today's top gainers in the biotech and medical technology space include Amylyx Pharmaceuticals, following positive Phase 3 LUCIDITY data; AVITA Medical, after favorable PermeaDerm-I clinical and cost results; CNS Pharmaceuticals, following a strategic financing and pipeline pivot; Orchestra BioMed, after securing strategic capital and advancing its hypertension program; and NeOnc Technologies, following encouraging Phase 2a data for NEO100, among others.
AMLX Gains On Positive Phase 3 LUCIDITY Data
Amylyx Pharmaceuticals, Inc. (AMLX) gained about 50% following positive topline results from its Phase 3 LUCIDITY trial of Avexitide in patients with post-bariatric hypoglycemia following Roux-en-Y gastric bypass surgery. The ...